Insider · CIK 0001880637
Rehan Verjee
director
Files at TYRA (Tyra Biosciences, Inc.). First filing Sep 11, 2026, latest Sep 11, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$20k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TYRA: Tyra Biosciences, Inc.
TYRAOct 9, 2026 · close 19.94
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | TYRAbuy Tyra Biosciences, Inc. | $20k 972 shares | - | +86% from low-44% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | TYRA Tyra Biosciences, Inc. | POpen-market purchase Common Stock | +972 | $20.58 | $20k | 972 | 31 d ago |
| May 29, 2025 | TYRA Tyra Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,200 | $0.00 | $0 | 22,200 | Jun 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.